SlideShare a Scribd company logo
1 of 4
Download to read offline
 
 
Voltas  
 Muted near‐term outlook!
July 03, 2014 
Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that 
the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision. 
Please refer to important disclosures and disclaimers at the end of the report 
 
Visit Update 
Kunal Sheth 
kunalsheth@plindia.com 
+91‐22‐66322257 
  
  
  
Rating  Accumulate 
Price  Rs222 
Target Price  Rs233 
Implied Upside   5.0% 
Sensex   25,841 
Nifty  7,725 
(Prices as on July 02, 2014) 
Trading data 
Market Cap. (Rs bn)  73.5 
Shares o/s (m)  330.7 
3M Avg. Daily value (Rs m)  1347.8 
Major shareholders 
Promoters   30.30% 
Foreign   18.09% 
Domestic Inst.  28.94% 
Public & Other   22.67% 
Stock Performance 
 (%)  1M  6M  12M 
Absolute  14.9  91.0  173.5 
Relative   10.2  67.3  140.7 
How we differ from Consensus 
EPS (Rs)  PL  Cons.  % Diff. 
2015  7.8  8.6  ‐9.3 
2016  10.4  11.1  ‐7.0 
 
Price Performance (RIC: VOLT.BO, BB: VOLT IN) 
 
Source: Bloomberg 
0
50
100
150
200
250
Jul‐13
Sep‐13
Nov‐13
Jan‐14
Mar‐14
May‐14
Jul‐14
(Rs)
We  met  the  management  of  Voltas.  The  key  takeaways  from  the  meet  are  1) 
Management expects ordering in the MEP segment to pick up in FY16 2) Legacy 
orders in the MEP segment might continue till Q3/Q4FY15 3) EMP segment may 
see a meaningful dip in revenues in FY15 4) Volume growth in the UCP segment 
remains below expectation for the quarter. The stock is currently trading at 21.5x 
FY16e earnings. We believe that a weak near‐term outlook will lead to stock under‐
performing the broader market in the near term. However, we remain positive on 
Voltas from medium/long term perspective due to (a) improving margin profile of 
fresh orders (b) strong consumer business franchisee and (c) healthy balance sheet 
and cash flow. We maintain ‘Accumulate’ on the stock.    
 MEP market to revive in FY16: The management is not seeing any meaningful 
improvement  in  the  order  pipeline,  especially  in  the  domestic  market  and 
expect  ordering  to  pick  up  in  FY16.  In the  international market,  management 
continues to remain positive due to opportunities in markets like UAE (Dubai 
2020  expo),  Abu  Dhabi,  Oman  etc,  despite  the  uncertainty  surrounding  the 
Qatar 2022 FIFA World Cup. The management continues to remain selective in 
order‐picking due to visa‐related issues in the KSA market. Management expects 
revival in the MEP market in FY16. Current order book is ~Rs36bn and ~60‐65% 
of the order book is from new margin orders. Management expects to complete 
low  margin  legacy  orders  by  Q3/Q4FY15  (except  Sidra,  where  the  closure 
timeline is uncertain).  
Contd..2 
 
 
   
Key financials (Y/e March)    2013 2014  2015E 2016E
Revenues (Rs m)  55,310 52,660  55,538 61,504
     Growth (%)  6.7 (4.8)  5.5 10.7
EBITDA (Rs m)  2,380 2,656  3,222 4,325
PAT (Rs m)  2,283 2,243  2,586 3,426
EPS (Rs)  6.9 6.8  7.8 10.4
     Growth (%)  40.9 (1.8)  15.3 32.5
Net DPS (Rs)  1.6 1.9  2.0 2.6
 
Profitability & Valuation    2013 2014  2015E 2016E
EBITDA margin (%)  4.3 5.0  5.8 7.0
RoE (%)  14.7 12.9  13.5 16.2
RoCE (%)  13.8 11.9  12.9 15.4
EV / sales (x)  1.3 1.4  1.3 1.1
EV / EBITDA (x)  30.5 27.6  22.4 16.2
PE (x)  32.2 32.8  28.4 21.5
P / BV (x)  4.5 4.0  3.7 3.3
Net dividend yield (%)  0.7 0.8  0.9 1.2
Source: Company Data; PL Research 
   
July 03, 2014  2
  Voltas 
 Volume  growth  in  UCP  segment  likely  to  be  muted,  EMP  segment  to  see 
meaningful de‐growth in FY15: AC segment’s volume growth for April and May 
was lower than expectation due to erratic climatic conditions. Though June has 
been  better  than  April/May,  overall  volumes  are  still  below  company 
expectations. Voltas reported a margin of 12.9% in the UCP segment due to few 
one‐offs and a better product mix (in favour of Split ACs). The company expects 
to report margins in the range of 10‐11% for FY15 in the UCP segment, while in 
the EMP segment, the company expects revenues to de‐grow meaningfully due 
to discontinuation of few principals (Bucyrus, LeTourneau). 
 Outlook and Valuation: Voltas is currently trading at 21.5x FY16e earnings. We 
have downgraded our earnings by ~10% for FY15 to factor in lower revenues in 
the  EMP  segment  and  slower‐than‐expected  ramp‐up  in  MEP  margins.  We 
believe weak near‐term outlook will lead to stock under‐performing the broader 
market in the near term. We remain positive on Voltas from medium/long term 
perspective  due  to  (a)  improving  margin  profile  of  fresh  orders  (b)  strong 
consumer  business  franchisee  (c)  healthy  balance  sheet  and  cash  flow.  We 
maintain ‘Accumulate’ on the stock.    
Exhibit 1: One year forward Price/Earnings 
38.1
18.5
16.4
3.5
26.0
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
45.0
Mar‐05
Sep‐05
Feb‐06
Jul‐06
Dec‐06
Jun‐07
Nov‐07
Apr‐08
Oct‐08
Mar‐09
Aug‐09
Jan‐10
Jul‐10
Dec‐10
May‐11
Oct‐11
Apr‐12
Sep‐12
Feb‐13
Jul‐13
Jan‐14
Jun‐14
P/E (x) Peak(x) Avg(x) Median(x) Min(x)
 
Source: Company Data, Bloomberg, PL Research 
 
 
   
   
July 03, 2014  3
  Voltas 
Income Statement (Rs m)           
Y/e March   2013  2014  2015E 2016E
Net Revenue  55,310  52,660  55,538 61,504
Raw Material Expenses  41,670  38,543  39,987 44,283
Gross Profit  13,639  14,118  15,551 17,221
Employee Cost  6,325  5,947  7,387 8,180
Other Expenses  4,934  5,515  4,942 4,716
EBITDA  2,380  2,656  3,222 4,325
Depr. & Amortization  278  248  418 442
Net Interest  326  226  361 361
Other Income  974  1,002  1,149 1,236
Profit before Tax  2,751  3,184  3,592 4,758
Total Tax  728  941  1,006 1,332
Profit after Tax  2,023  2,243  2,586 3,426
Ex‐Od items / Min. Int.  —  —  — —
Adj. PAT  2,283  2,243  2,586 3,426
Avg. Shares O/S (m)  330.7  330.7  330.7 330.7
EPS (Rs.)  6.9  6.8  7.8 10.4
 
Cash Flow Abstract (Rs m)    
Y/e March     2013  2014  2015E 2016E
C/F from Operations  2,534  3,230  2,760 3,763
C/F from Investing  (841)  (3,547)  (300) (300)
C/F from Financing  (570)  (928)  (1,171) (1,363)
Inc. / Dec. in Cash  1,122  (1,245)  1,290 2,100
Opening Cash  2,710  3,832  2,588 3,877
Closing Cash  3,832  2,588  3,877 5,978
FCFF  2,111  2,705  2,100 3,102
FCFE  2,472  2,721  2,046 3,102
 
 
 
Key Financial Metrics 
Y/e March             2013  2014  2015E 2016E
Growth     
Revenue (%)  6.7  (4.8)  5.5 10.7
EBITDA (%)  (29.3)  11.6  21.3 34.2
PAT (%)  40.9  (1.8)  15.3 32.5
EPS (%)  40.9  (1.8)  15.3 32.5
Profitability     
EBITDA Margin (%)  4.3  5.0  5.8 7.0
PAT Margin (%)  4.1  4.3  4.7 5.6
RoCE (%)  13.8  11.9  12.9 15.4
RoE (%)  14.7  12.9  13.5 16.2
Balance Sheet     
Net Debt : Equity  (0.1)  —  (0.1) (0.2)
Net Wrkng Cap. (days)  26  24  (6) (6)
Valuation     
PER (x)  32.2  32.8  28.4 21.5
P / B (x)  4.5  4.0  3.7 3.3
EV / EBITDA (x)  30.5  27.6  22.4 16.2
EV / Sales (x)  1.3  1.4  1.3 1.1
Earnings Quality     
Eff. Tax Rate  24.2  29.6  28.0 28.0
Other Inc / PBT  33.7  31.5  32.0 26.0
Eff. Depr. Rate (%)  6.0  5.0  8.0 8.0
FCFE / PAT  108.3  121.3  79.1 90.6
Source: Company Data, PL Research. 
 
   
Balance Sheet Abstract (Rs m)   
Y/e March      2013  2014  2015E 2016E
Shareholder's Funds  16,325  18,317  19,930 22,338
Total Debt  2,612  2,629  2,575 2,575
Other Liabilities  118  138  152 167
Total Liabilities  19,056  21,084  22,657 25,081
Net Fixed Assets  2,156  2,208  2,089 1,947
Goodwill  888  799  826 826
Investments  4,074  7,320  7,320 7,320
Net Current Assets  11,693  10,499  12,163 14,729
     Cash & Equivalents  3,498  2,818  3,877 5,978
     Other Current Assets  34,852  34,157  32,172 35,483
     Current Liabilities  26,657  26,476  23,887 26,732
Other Assets  245  259  259 259
Total Assets  19,055  21,084  22,657 25,081
 
 
 
 
Quarterly Financials (Rs m)     
Y/e March      Q2FY14  Q3FY14  Q4FY14 Q1FY15E
Net Revenue  10,805  11,194  14,628 15,366
EBITDA  432  675  1,054 1,076
% of revenue  4.0  6.0  7.2 7.0
Depr. & Amortization  60  60  69 70
Net Interest  55  46  65 85
Other Income  303  170  308 250
Profit before Tax  620  740  1,228 1,171
Total Tax  196  164  392 375
Profit after Tax  424  577  1,010 796
Adj. PAT  424  577  836 796
Source: Company Data, PL Research. 
 
   
July 03, 2014  4
  Voltas 
 
 
 
 
 
Prabhudas Lilladher Pvt. Ltd. 
3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai‐400 018, India 
Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209 
Rating Distribution of Research Coverage   
28.4%
53.2%
18.3%
0.0%
0%
10%
20%
30%
40%
50%
60%
BUY Accumulate Reduce Sell
% of Total Coverage
 
PL’s Recommendation Nomenclature     
BUY   :  Over 15% Outperformance to Sensex over 12‐months  Accumulate  :  Outperformance to Sensex over 12‐months 
Reduce  :  Underperformance to Sensex over 12‐months  Sell  :  Over 15% underperformance to Sensex over 12‐months 
Trading Buy  :  Over 10% absolute upside in 1‐month  Trading Sell  :  Over 10% absolute decline in 1‐month 
Not Rated (NR)  :  No specific call on the stock  Under Review (UR)  :  Rating likely to change shortly 
This  document  has  been  prepared  by  the  Research  Division  of  Prabhudas  Lilladher  Pvt.  Ltd.  Mumbai,  India  (PL)  and  is  meant  for  use  by  the  recipient  only  as 
information and is not for circulation.  This document is not to be reported or copied or made available to others without prior permission of PL. It should not be 
considered or taken as an offer to sell or a solicitation to buy or sell any security. 
The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy 
or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accept any responsibility of whatsoever nature for the information, 
statements and opinion given, made available or expressed herein or for any omission therein. 
Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The 
suitability  or  otherwise  of  any  investments  will  depend  upon  the  recipient's  particular  circumstances  and,  in  case  of  doubt,  advice  should  be  sought  from  an 
independent expert/advisor. 
Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or 
engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. 
We may from time to time solicit or perform investment banking or other services for any company mentioned in this document. 

More Related Content

What's hot

Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buy
Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buyWelspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buy
Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buyIndiaNotes.com
 
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial Results
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial ResultsSecond Quarter of Fiscal Year Ending March 2016 Briefing on Financial Results
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial ResultsRicohLease
 
Bajaj electricals ru2 qfy2011-271010
Bajaj electricals ru2 qfy2011-271010Bajaj electricals ru2 qfy2011-271010
Bajaj electricals ru2 qfy2011-271010Angel Broking
 
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
 Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, marginsIndiaNotes.com
 
Corporation bank ru2 qfy2011-221010
Corporation bank ru2 qfy2011-221010Corporation bank ru2 qfy2011-221010
Corporation bank ru2 qfy2011-221010Angel Broking
 
Credit Corp - turnaround in performance
Credit Corp - turnaround in performance Credit Corp - turnaround in performance
Credit Corp - turnaround in performance George Gabriel
 
CFA_Seattle_Team 7_Presentation
CFA_Seattle_Team 7_PresentationCFA_Seattle_Team 7_Presentation
CFA_Seattle_Team 7_PresentationJin Hongzi
 
Gsk stock-valuation-final (group 09)
Gsk stock-valuation-final (group 09)Gsk stock-valuation-final (group 09)
Gsk stock-valuation-final (group 09)Sabiha Zaman Khan
 
Glaxo smithkline case study
Glaxo smithkline case studyGlaxo smithkline case study
Glaxo smithkline case studyKing Abidi
 
Financial Analysis HCC
Financial Analysis HCCFinancial Analysis HCC
Financial Analysis HCCJaspal Bhatia
 
Idea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buyIdea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buyIndiaNotes.com
 
Abbott's financial ratio analysis
Abbott's financial ratio analysisAbbott's financial ratio analysis
Abbott's financial ratio analysisShraddha Bhatt
 
pwc-stock-compensation-september-2014
pwc-stock-compensation-september-2014pwc-stock-compensation-september-2014
pwc-stock-compensation-september-2014Ken Stoler
 
Motherson Sumi Systems - Result Update
Motherson Sumi Systems - Result UpdateMotherson Sumi Systems - Result Update
Motherson Sumi Systems - Result UpdateAngel Broking
 
Uniglobe presentation 2012 firm size, book to-market ratio and stock returns
Uniglobe presentation 2012 firm size, book to-market ratio and stock returnsUniglobe presentation 2012 firm size, book to-market ratio and stock returns
Uniglobe presentation 2012 firm size, book to-market ratio and stock returnsNiyam Shrestha
 

What's hot (20)

Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buy
Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buyWelspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buy
Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buy
 
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial Results
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial ResultsSecond Quarter of Fiscal Year Ending March 2016 Briefing on Financial Results
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial Results
 
Bajaj electricals ru2 qfy2011-271010
Bajaj electricals ru2 qfy2011-271010Bajaj electricals ru2 qfy2011-271010
Bajaj electricals ru2 qfy2011-271010
 
Pitchbook
PitchbookPitchbook
Pitchbook
 
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
 Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
 
Corporation bank ru2 qfy2011-221010
Corporation bank ru2 qfy2011-221010Corporation bank ru2 qfy2011-221010
Corporation bank ru2 qfy2011-221010
 
Credit Corp - turnaround in performance
Credit Corp - turnaround in performance Credit Corp - turnaround in performance
Credit Corp - turnaround in performance
 
CFA_Seattle_Team 7_Presentation
CFA_Seattle_Team 7_PresentationCFA_Seattle_Team 7_Presentation
CFA_Seattle_Team 7_Presentation
 
Gsk stock-valuation-final (group 09)
Gsk stock-valuation-final (group 09)Gsk stock-valuation-final (group 09)
Gsk stock-valuation-final (group 09)
 
Glaxo smithkline case study
Glaxo smithkline case studyGlaxo smithkline case study
Glaxo smithkline case study
 
Sonata IC
Sonata ICSonata IC
Sonata IC
 
Financial Analysis HCC
Financial Analysis HCCFinancial Analysis HCC
Financial Analysis HCC
 
Idea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buyIdea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buy
 
Abbott's financial ratio analysis
Abbott's financial ratio analysisAbbott's financial ratio analysis
Abbott's financial ratio analysis
 
Credit Analysis Of HCC
Credit Analysis Of HCCCredit Analysis Of HCC
Credit Analysis Of HCC
 
Larsen & toubro.ppt_25
Larsen & toubro.ppt_25Larsen & toubro.ppt_25
Larsen & toubro.ppt_25
 
pwc-stock-compensation-september-2014
pwc-stock-compensation-september-2014pwc-stock-compensation-september-2014
pwc-stock-compensation-september-2014
 
Motherson Sumi Systems - Result Update
Motherson Sumi Systems - Result UpdateMotherson Sumi Systems - Result Update
Motherson Sumi Systems - Result Update
 
Uniglobe presentation 2012 firm size, book to-market ratio and stock returns
Uniglobe presentation 2012 firm size, book to-market ratio and stock returnsUniglobe presentation 2012 firm size, book to-market ratio and stock returns
Uniglobe presentation 2012 firm size, book to-market ratio and stock returns
 
Presentation
PresentationPresentation
Presentation
 

Similar to Voltas Visit Update: Muted near-term outlook - Prabhudas Lilladher

MindTree: Prospect looks upbeat; buy
MindTree: Prospect looks upbeat; buyMindTree: Prospect looks upbeat; buy
MindTree: Prospect looks upbeat; buyIndiaNotes.com
 
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas LilladherKSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas LilladherIndiaNotes.com
 
Prabhudas lilladher techmahindra_29june_2015
Prabhudas lilladher techmahindra_29june_2015Prabhudas lilladher techmahindra_29june_2015
Prabhudas lilladher techmahindra_29june_2015IndiaNotes.com
 
Pl shree cement_04may15[1]
Pl shree cement_04may15[1]Pl shree cement_04may15[1]
Pl shree cement_04may15[1]IndiaNotes.com
 
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presence
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presencePersistent Systems: Acquired RGen Solutions, Strengthening OPD presence
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presenceIndiaNotes.com
 
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...IndiaNotes.com
 
Cipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15ECipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15EIndiaNotes.com
 
Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...
Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...
Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...IndiaNotes.com
 
Buy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas LilladherBuy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas LilladherIndiaNotes.com
 
State Bank of India: Absolute valuations, accumulate - Prabhudas Lilladher
State Bank of India: Absolute valuations, accumulate - Prabhudas LilladherState Bank of India: Absolute valuations, accumulate - Prabhudas Lilladher
State Bank of India: Absolute valuations, accumulate - Prabhudas LilladherIndiaNotes.com
 
Punjab National Bank Q1FY15: Sane performance sanity in the quarter
 Punjab National Bank Q1FY15: Sane performance sanity in the quarter Punjab National Bank Q1FY15: Sane performance sanity in the quarter
Punjab National Bank Q1FY15: Sane performance sanity in the quarterIndiaNotes.com
 
Stock Tip: Buy this stock for a target of Rs270
Stock Tip: Buy this stock for a target of Rs270Stock Tip: Buy this stock for a target of Rs270
Stock Tip: Buy this stock for a target of Rs270IndiaNotes.com
 
Hindustan Zinc: Still lot of juice left; buy
Hindustan Zinc: Still lot of juice left; buyHindustan Zinc: Still lot of juice left; buy
Hindustan Zinc: Still lot of juice left; buyIndiaNotes.com
 
Crompton Greaves: Ideally places to benefit from an improved economic growth,...
Crompton Greaves: Ideally places to benefit from an improved economic growth,...Crompton Greaves: Ideally places to benefit from an improved economic growth,...
Crompton Greaves: Ideally places to benefit from an improved economic growth,...IndiaNotes.com
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 
HCL acquires Trygstad, Prabhudas Lilladher recommend 'accumulate'
 HCL acquires Trygstad, Prabhudas Lilladher recommend 'accumulate' HCL acquires Trygstad, Prabhudas Lilladher recommend 'accumulate'
HCL acquires Trygstad, Prabhudas Lilladher recommend 'accumulate'IndiaNotes.com
 
Zee 1QFY18
Zee 1QFY18Zee 1QFY18
Zee 1QFY18Mohit Jn
 
Firstsource 1QFY18
Firstsource 1QFY18Firstsource 1QFY18
Firstsource 1QFY18Mohit Jn
 
FSOL 1QFY18
FSOL 1QFY18FSOL 1QFY18
FSOL 1QFY18Mohit Jn
 

Similar to Voltas Visit Update: Muted near-term outlook - Prabhudas Lilladher (20)

MindTree: Prospect looks upbeat; buy
MindTree: Prospect looks upbeat; buyMindTree: Prospect looks upbeat; buy
MindTree: Prospect looks upbeat; buy
 
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas LilladherKSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
 
Prabhudas lilladher techmahindra_29june_2015
Prabhudas lilladher techmahindra_29june_2015Prabhudas lilladher techmahindra_29june_2015
Prabhudas lilladher techmahindra_29june_2015
 
Pl shree cement_04may15[1]
Pl shree cement_04may15[1]Pl shree cement_04may15[1]
Pl shree cement_04may15[1]
 
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presence
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presencePersistent Systems: Acquired RGen Solutions, Strengthening OPD presence
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presence
 
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...
 
Cipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15ECipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15E
 
Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...
Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...
Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...
 
Buy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas LilladherBuy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
Buy Britannia Industries for a target of Rs1110 - Prabhudas Lilladher
 
Bata india
Bata indiaBata india
Bata india
 
State Bank of India: Absolute valuations, accumulate - Prabhudas Lilladher
State Bank of India: Absolute valuations, accumulate - Prabhudas LilladherState Bank of India: Absolute valuations, accumulate - Prabhudas Lilladher
State Bank of India: Absolute valuations, accumulate - Prabhudas Lilladher
 
Punjab National Bank Q1FY15: Sane performance sanity in the quarter
 Punjab National Bank Q1FY15: Sane performance sanity in the quarter Punjab National Bank Q1FY15: Sane performance sanity in the quarter
Punjab National Bank Q1FY15: Sane performance sanity in the quarter
 
Stock Tip: Buy this stock for a target of Rs270
Stock Tip: Buy this stock for a target of Rs270Stock Tip: Buy this stock for a target of Rs270
Stock Tip: Buy this stock for a target of Rs270
 
Hindustan Zinc: Still lot of juice left; buy
Hindustan Zinc: Still lot of juice left; buyHindustan Zinc: Still lot of juice left; buy
Hindustan Zinc: Still lot of juice left; buy
 
Crompton Greaves: Ideally places to benefit from an improved economic growth,...
Crompton Greaves: Ideally places to benefit from an improved economic growth,...Crompton Greaves: Ideally places to benefit from an improved economic growth,...
Crompton Greaves: Ideally places to benefit from an improved economic growth,...
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
HCL acquires Trygstad, Prabhudas Lilladher recommend 'accumulate'
 HCL acquires Trygstad, Prabhudas Lilladher recommend 'accumulate' HCL acquires Trygstad, Prabhudas Lilladher recommend 'accumulate'
HCL acquires Trygstad, Prabhudas Lilladher recommend 'accumulate'
 
Zee 1QFY18
Zee 1QFY18Zee 1QFY18
Zee 1QFY18
 
Firstsource 1QFY18
Firstsource 1QFY18Firstsource 1QFY18
Firstsource 1QFY18
 
FSOL 1QFY18
FSOL 1QFY18FSOL 1QFY18
FSOL 1QFY18
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityIndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetIndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 

Recently uploaded

Unveiling the Top Chartered Accountants in India and Their Staggering Net Worth
Unveiling the Top Chartered Accountants in India and Their Staggering Net WorthUnveiling the Top Chartered Accountants in India and Their Staggering Net Worth
Unveiling the Top Chartered Accountants in India and Their Staggering Net WorthShaheen Kumar
 
Lundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfLundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfAdnet Communications
 
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证rjrjkk
 
20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdfAdnet Communications
 
Stock Market Brief Deck for "this does not happen often".pdf
Stock Market Brief Deck for "this does not happen often".pdfStock Market Brief Deck for "this does not happen often".pdf
Stock Market Brief Deck for "this does not happen often".pdfMichael Silva
 
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With RoomVIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Roomdivyansh0kumar0
 
House of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview documentHouse of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview documentHenry Tapper
 
Monthly Market Risk Update: April 2024 [SlideShare]
Monthly Market Risk Update: April 2024 [SlideShare]Monthly Market Risk Update: April 2024 [SlideShare]
Monthly Market Risk Update: April 2024 [SlideShare]Commonwealth
 
fca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdffca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdfHenry Tapper
 
Mulki Call Girls 7001305949 WhatsApp Number 24x7 Best Services
Mulki Call Girls 7001305949 WhatsApp Number 24x7 Best ServicesMulki Call Girls 7001305949 WhatsApp Number 24x7 Best Services
Mulki Call Girls 7001305949 WhatsApp Number 24x7 Best Servicesnajka9823
 
Classical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam SmithClassical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam SmithAdamYassin2
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
Q3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesQ3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesMarketing847413
 
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130Suhani Kapoor
 
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证jdkhjh
 
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...Henry Tapper
 
SBP-Market-Operations and market managment
SBP-Market-Operations and market managmentSBP-Market-Operations and market managment
SBP-Market-Operations and market managmentfactical
 
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Sapana Sha
 
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdfBPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdfHenry Tapper
 

Recently uploaded (20)

Unveiling the Top Chartered Accountants in India and Their Staggering Net Worth
Unveiling the Top Chartered Accountants in India and Their Staggering Net WorthUnveiling the Top Chartered Accountants in India and Their Staggering Net Worth
Unveiling the Top Chartered Accountants in India and Their Staggering Net Worth
 
Lundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfLundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdf
 
Commercial Bank Economic Capsule - April 2024
Commercial Bank Economic Capsule - April 2024Commercial Bank Economic Capsule - April 2024
Commercial Bank Economic Capsule - April 2024
 
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
 
20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf
 
Stock Market Brief Deck for "this does not happen often".pdf
Stock Market Brief Deck for "this does not happen often".pdfStock Market Brief Deck for "this does not happen often".pdf
Stock Market Brief Deck for "this does not happen often".pdf
 
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With RoomVIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
 
House of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview documentHouse of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview document
 
Monthly Market Risk Update: April 2024 [SlideShare]
Monthly Market Risk Update: April 2024 [SlideShare]Monthly Market Risk Update: April 2024 [SlideShare]
Monthly Market Risk Update: April 2024 [SlideShare]
 
fca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdffca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdf
 
Mulki Call Girls 7001305949 WhatsApp Number 24x7 Best Services
Mulki Call Girls 7001305949 WhatsApp Number 24x7 Best ServicesMulki Call Girls 7001305949 WhatsApp Number 24x7 Best Services
Mulki Call Girls 7001305949 WhatsApp Number 24x7 Best Services
 
Classical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam SmithClassical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam Smith
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
 
Q3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesQ3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast Slides
 
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
VIP Call Girls Service Dilsukhnagar Hyderabad Call +91-8250192130
 
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证
原版1:1复刻堪萨斯大学毕业证KU毕业证留信学历认证
 
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
 
SBP-Market-Operations and market managment
SBP-Market-Operations and market managmentSBP-Market-Operations and market managment
SBP-Market-Operations and market managment
 
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
 
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdfBPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
 

Voltas Visit Update: Muted near-term outlook - Prabhudas Lilladher

  • 1.     Voltas    Muted near‐term outlook! July 03, 2014  Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that  the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision.  Please refer to important disclosures and disclaimers at the end of the report    Visit Update  Kunal Sheth  kunalsheth@plindia.com  +91‐22‐66322257           Rating  Accumulate  Price  Rs222  Target Price  Rs233  Implied Upside   5.0%  Sensex   25,841  Nifty  7,725  (Prices as on July 02, 2014)  Trading data  Market Cap. (Rs bn)  73.5  Shares o/s (m)  330.7  3M Avg. Daily value (Rs m)  1347.8  Major shareholders  Promoters   30.30%  Foreign   18.09%  Domestic Inst.  28.94%  Public & Other   22.67%  Stock Performance   (%)  1M  6M  12M  Absolute  14.9  91.0  173.5  Relative   10.2  67.3  140.7  How we differ from Consensus  EPS (Rs)  PL  Cons.  % Diff.  2015  7.8  8.6  ‐9.3  2016  10.4  11.1  ‐7.0    Price Performance (RIC: VOLT.BO, BB: VOLT IN)    Source: Bloomberg  0 50 100 150 200 250 Jul‐13 Sep‐13 Nov‐13 Jan‐14 Mar‐14 May‐14 Jul‐14 (Rs) We  met  the  management  of  Voltas.  The  key  takeaways  from  the  meet  are  1)  Management expects ordering in the MEP segment to pick up in FY16 2) Legacy  orders in the MEP segment might continue till Q3/Q4FY15 3) EMP segment may  see a meaningful dip in revenues in FY15 4) Volume growth in the UCP segment  remains below expectation for the quarter. The stock is currently trading at 21.5x  FY16e earnings. We believe that a weak near‐term outlook will lead to stock under‐ performing the broader market in the near term. However, we remain positive on  Voltas from medium/long term perspective due to (a) improving margin profile of  fresh orders (b) strong consumer business franchisee and (c) healthy balance sheet  and cash flow. We maintain ‘Accumulate’ on the stock.      MEP market to revive in FY16: The management is not seeing any meaningful  improvement  in  the  order  pipeline,  especially  in  the  domestic  market  and  expect  ordering  to  pick  up  in  FY16.  In the  international market,  management  continues to remain positive due to opportunities in markets like UAE (Dubai  2020  expo),  Abu  Dhabi,  Oman  etc,  despite  the  uncertainty  surrounding  the  Qatar 2022 FIFA World Cup. The management continues to remain selective in  order‐picking due to visa‐related issues in the KSA market. Management expects  revival in the MEP market in FY16. Current order book is ~Rs36bn and ~60‐65%  of the order book is from new margin orders. Management expects to complete  low  margin  legacy  orders  by  Q3/Q4FY15  (except  Sidra,  where  the  closure  timeline is uncertain).   Contd..2          Key financials (Y/e March)    2013 2014  2015E 2016E Revenues (Rs m)  55,310 52,660  55,538 61,504      Growth (%)  6.7 (4.8)  5.5 10.7 EBITDA (Rs m)  2,380 2,656  3,222 4,325 PAT (Rs m)  2,283 2,243  2,586 3,426 EPS (Rs)  6.9 6.8  7.8 10.4      Growth (%)  40.9 (1.8)  15.3 32.5 Net DPS (Rs)  1.6 1.9  2.0 2.6   Profitability & Valuation    2013 2014  2015E 2016E EBITDA margin (%)  4.3 5.0  5.8 7.0 RoE (%)  14.7 12.9  13.5 16.2 RoCE (%)  13.8 11.9  12.9 15.4 EV / sales (x)  1.3 1.4  1.3 1.1 EV / EBITDA (x)  30.5 27.6  22.4 16.2 PE (x)  32.2 32.8  28.4 21.5 P / BV (x)  4.5 4.0  3.7 3.3 Net dividend yield (%)  0.7 0.8  0.9 1.2 Source: Company Data; PL Research 
  • 2.     July 03, 2014  2   Voltas   Volume  growth  in  UCP  segment  likely  to  be  muted,  EMP  segment  to  see  meaningful de‐growth in FY15: AC segment’s volume growth for April and May  was lower than expectation due to erratic climatic conditions. Though June has  been  better  than  April/May,  overall  volumes  are  still  below  company  expectations. Voltas reported a margin of 12.9% in the UCP segment due to few  one‐offs and a better product mix (in favour of Split ACs). The company expects  to report margins in the range of 10‐11% for FY15 in the UCP segment, while in  the EMP segment, the company expects revenues to de‐grow meaningfully due  to discontinuation of few principals (Bucyrus, LeTourneau).   Outlook and Valuation: Voltas is currently trading at 21.5x FY16e earnings. We  have downgraded our earnings by ~10% for FY15 to factor in lower revenues in  the  EMP  segment  and  slower‐than‐expected  ramp‐up  in  MEP  margins.  We  believe weak near‐term outlook will lead to stock under‐performing the broader  market in the near term. We remain positive on Voltas from medium/long term  perspective  due  to  (a)  improving  margin  profile  of  fresh  orders  (b)  strong  consumer  business  franchisee  (c)  healthy  balance  sheet  and  cash  flow.  We  maintain ‘Accumulate’ on the stock.     Exhibit 1: One year forward Price/Earnings  38.1 18.5 16.4 3.5 26.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 45.0 Mar‐05 Sep‐05 Feb‐06 Jul‐06 Dec‐06 Jun‐07 Nov‐07 Apr‐08 Oct‐08 Mar‐09 Aug‐09 Jan‐10 Jul‐10 Dec‐10 May‐11 Oct‐11 Apr‐12 Sep‐12 Feb‐13 Jul‐13 Jan‐14 Jun‐14 P/E (x) Peak(x) Avg(x) Median(x) Min(x)   Source: Company Data, Bloomberg, PL Research         
  • 3.     July 03, 2014  3   Voltas  Income Statement (Rs m)            Y/e March   2013  2014  2015E 2016E Net Revenue  55,310  52,660  55,538 61,504 Raw Material Expenses  41,670  38,543  39,987 44,283 Gross Profit  13,639  14,118  15,551 17,221 Employee Cost  6,325  5,947  7,387 8,180 Other Expenses  4,934  5,515  4,942 4,716 EBITDA  2,380  2,656  3,222 4,325 Depr. & Amortization  278  248  418 442 Net Interest  326  226  361 361 Other Income  974  1,002  1,149 1,236 Profit before Tax  2,751  3,184  3,592 4,758 Total Tax  728  941  1,006 1,332 Profit after Tax  2,023  2,243  2,586 3,426 Ex‐Od items / Min. Int.  —  —  — — Adj. PAT  2,283  2,243  2,586 3,426 Avg. Shares O/S (m)  330.7  330.7  330.7 330.7 EPS (Rs.)  6.9  6.8  7.8 10.4   Cash Flow Abstract (Rs m)     Y/e March     2013  2014  2015E 2016E C/F from Operations  2,534  3,230  2,760 3,763 C/F from Investing  (841)  (3,547)  (300) (300) C/F from Financing  (570)  (928)  (1,171) (1,363) Inc. / Dec. in Cash  1,122  (1,245)  1,290 2,100 Opening Cash  2,710  3,832  2,588 3,877 Closing Cash  3,832  2,588  3,877 5,978 FCFF  2,111  2,705  2,100 3,102 FCFE  2,472  2,721  2,046 3,102       Key Financial Metrics  Y/e March             2013  2014  2015E 2016E Growth      Revenue (%)  6.7  (4.8)  5.5 10.7 EBITDA (%)  (29.3)  11.6  21.3 34.2 PAT (%)  40.9  (1.8)  15.3 32.5 EPS (%)  40.9  (1.8)  15.3 32.5 Profitability      EBITDA Margin (%)  4.3  5.0  5.8 7.0 PAT Margin (%)  4.1  4.3  4.7 5.6 RoCE (%)  13.8  11.9  12.9 15.4 RoE (%)  14.7  12.9  13.5 16.2 Balance Sheet      Net Debt : Equity  (0.1)  —  (0.1) (0.2) Net Wrkng Cap. (days)  26  24  (6) (6) Valuation      PER (x)  32.2  32.8  28.4 21.5 P / B (x)  4.5  4.0  3.7 3.3 EV / EBITDA (x)  30.5  27.6  22.4 16.2 EV / Sales (x)  1.3  1.4  1.3 1.1 Earnings Quality      Eff. Tax Rate  24.2  29.6  28.0 28.0 Other Inc / PBT  33.7  31.5  32.0 26.0 Eff. Depr. Rate (%)  6.0  5.0  8.0 8.0 FCFE / PAT  108.3  121.3  79.1 90.6 Source: Company Data, PL Research.        Balance Sheet Abstract (Rs m)    Y/e March      2013  2014  2015E 2016E Shareholder's Funds  16,325  18,317  19,930 22,338 Total Debt  2,612  2,629  2,575 2,575 Other Liabilities  118  138  152 167 Total Liabilities  19,056  21,084  22,657 25,081 Net Fixed Assets  2,156  2,208  2,089 1,947 Goodwill  888  799  826 826 Investments  4,074  7,320  7,320 7,320 Net Current Assets  11,693  10,499  12,163 14,729      Cash & Equivalents  3,498  2,818  3,877 5,978      Other Current Assets  34,852  34,157  32,172 35,483      Current Liabilities  26,657  26,476  23,887 26,732 Other Assets  245  259  259 259 Total Assets  19,055  21,084  22,657 25,081         Quarterly Financials (Rs m)      Y/e March      Q2FY14  Q3FY14  Q4FY14 Q1FY15E Net Revenue  10,805  11,194  14,628 15,366 EBITDA  432  675  1,054 1,076 % of revenue  4.0  6.0  7.2 7.0 Depr. & Amortization  60  60  69 70 Net Interest  55  46  65 85 Other Income  303  170  308 250 Profit before Tax  620  740  1,228 1,171 Total Tax  196  164  392 375 Profit after Tax  424  577  1,010 796 Adj. PAT  424  577  836 796 Source: Company Data, PL Research.   
  • 4.     July 03, 2014  4   Voltas            Prabhudas Lilladher Pvt. Ltd.  3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai‐400 018, India  Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209  Rating Distribution of Research Coverage    28.4% 53.2% 18.3% 0.0% 0% 10% 20% 30% 40% 50% 60% BUY Accumulate Reduce Sell % of Total Coverage   PL’s Recommendation Nomenclature      BUY   :  Over 15% Outperformance to Sensex over 12‐months  Accumulate  :  Outperformance to Sensex over 12‐months  Reduce  :  Underperformance to Sensex over 12‐months  Sell  :  Over 15% underperformance to Sensex over 12‐months  Trading Buy  :  Over 10% absolute upside in 1‐month  Trading Sell  :  Over 10% absolute decline in 1‐month  Not Rated (NR)  :  No specific call on the stock  Under Review (UR)  :  Rating likely to change shortly  This  document  has  been  prepared  by  the  Research  Division  of  Prabhudas  Lilladher  Pvt.  Ltd.  Mumbai,  India  (PL)  and  is  meant  for  use  by  the  recipient  only  as  information and is not for circulation.  This document is not to be reported or copied or made available to others without prior permission of PL. It should not be  considered or taken as an offer to sell or a solicitation to buy or sell any security.  The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy  or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accept any responsibility of whatsoever nature for the information,  statements and opinion given, made available or expressed herein or for any omission therein.  Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The  suitability  or  otherwise  of  any  investments  will  depend  upon  the  recipient's  particular  circumstances  and,  in  case  of  doubt,  advice  should  be  sought  from  an  independent expert/advisor.  Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or  engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication.  We may from time to time solicit or perform investment banking or other services for any company mentioned in this document.